Skip to main navigation Skip to search Skip to main content

Estimating the cost-effectiveness of tumor treating fields (Ttfields) therapy with an immune checkpoint inhibitor or docetaxel in metastatic non-small cell lung cancer

  • Wesley Furnback
  • , Elizabeth Wu
  • , Cloe Ying Chee Koh
  • , Jorge Fernando Nino De Rivera Guzman
  • , Christian Kruhl
  • , Rupesh Kotecha
  • , Bruce Cm Wang

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)55-68
Number of pages14
JournalClinicoEconomics and Outcomes Research
Volume17
DOIs
StatePublished - 2025

ASJC Scopus Subject Areas

  • Economics, Econometrics and Finance (miscellaneous)
  • Health Policy

Keywords

  • Chemotherapy
  • Cost-effectiveness
  • Immunotherapy
  • Lung cancer
  • Tumor Treating Fields

Cite this